Prevention of Infectious Mastitis by Oral Administration of Lactobacillus salivarius PS2 During Late Pregnancy.
- 2015-11-26
- RCT · n = 108
- Clinical Infectious Diseases 62(5)
- L. Fernández
- Nívia Cárdenas
- Rebeca Arroyo
- S. Manzano
- E. Jiménez
- V. Martín
- J. M. Rodríguez
- PubMed: 26611780
- DOI: 10.1093/cid/civ974
- High evidence
- Highly Cited
- Rigorous Journal
- Clinical
the percentage of women with mastitis in the probiotic group (25% [n = 14]) was significantly lower than in the control group (57% [n = 30]).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes